Press Releases by Year
Nanology in the News
Presentations & Publications
Jan 8-10 : ASCO GI Cancers Symposium | San Francisco
Jan 10 : Oncology Innovation Forum | San Francisco
Jan 12-14 : Biotech Showcase | San Francisco
Jan 12-15 : JP Morgan 44th Annual Healthcare Conference
NanOlogy Appoints David J. Arthur as Chief Executive Officer to Drive Clinical Development of its Large Surface Area Microparticle (LSAM) Investigational Drug Portfolio
NanOlogy Unveils Drug Development Program for Rare Pediatric Brainstem Tumor
NanOlogy Publishes Research Articles on the Immunomodulatory Effects of its Large Surface Area Microparticle Investigational Drugs
See All Press Releases
OncLive: LSAM-PTX Demonstrates Disease Control, Safety in Locally Advanced Pancreatic Cancer
OncLive: LSAM-DTX Effective and Safe in NMIBC Using Direct, Multifaceted Approach
Target Oncology: Direct and Multifaceted LSAM-DTX Treatment May Be Safe and Effective in NMIBC
See Nanology in the News Archive
Therapeutic Advances in Medical Oncology: Systemic and locoregional therapies for cutaneous metastases from breast cancer: state of art and new frontiers in treatment approach
European Urology: A Systemic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer
Journal of Thoracic Oncology: Phase 2a Intratumoral Large Surface Area Microparticle Paclitaxel in Stage 3/4 Lung Cancer
JDDG: Cutaneous metastases: From epidemiology to therapy
Journal for ImmunoTherapy of Cancer: Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease
See All Presentations & Publications
